Citation only
via Europe PMC
Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes.
Magalhães PLM, Rassi T, Amaral DC, Veiga DM, Oliveira AKR, Gonzalez JVP, Silva LO, Caixeta GL, Maia M, Louzada RN.
American journal of ophthalmology · 2026
Abstract
<h4>Topic</h4>This systematic review and meta-analysis evaluated the association between statin use and the prevalence, incidence, and progression of age-related macular degeneration (AMD).<h4>Clinical relevance</h4>AMD is a major cause of vision loss in older adults, many of whom receive statins for cardiovascular prevention.<h4>Methods</h4>We searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library through October 2025 for randomized trials and cohort, case-control, and cross-sectional studies with comparators. We assessed risk of bias with tools appropriate to each design and pooled effect measures separately using random-effects models. The protocol was registered in PROSPERO.<h4>Results</h4>Twenty-eight studies included 1,918,120 participants. Pooled odds ratios (ORs) for the prevalence of any, early, and late AMD were 1.03 (95% confidence interval [CI], 0.86-1.24), 1.10 (95% CI, 0.92-1.31), and 0.75 (95% CI, 0.46-1.25), respectively. For incidence of any AMD, the pooled hazard ratio (HR) was 1.04 (95% CI, 0.82-1.31) and the OR was 0.76 (95% CI, 0.43-1.34), with substantial heterogeneity. For neovascular AMD incidence, different study subsets suggested lower hazard (HR, 0.72; 95% CI, 0.60-0.85) and higher risk (risk ratio, 1.31; 95% CI, 1.18-1.44); the OR was inconclusive (0.93; 95% CI, 0.82-1.05). Progression evidence was limited and heterogeneous. Ten of 12 longitudinal nonrandomized studies had serious overall risk of bias.<h4>Conclusion</h4>The evidence was of very low certainty and insufficient to establish a protective or harmful effect of statins on AMD. These findings do not support prescribing statins specifically for AMD or discontinuing otherwise indicated therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.ajo.2026.11.005
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
PLM, M., T, R., DC, A., DM, V., AKR, O., JVP, G., LO, S., GL, C., M, M., & RN., L. (2026). Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes. <em>American journal of ophthalmology</em>. https://doi.org/10.1016/j.ajo.2026.11.005
Vancouver
PLM M, T R, DC A, DM V, AKR O, JVP G, et al. Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes. American journal of ophthalmology. 2026. doi:10.1016/j.ajo.2026.11.005.
BibTeX
@article{magalhes2026Statin,
title = {Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes.},
author = {Magalhães PLM and Rassi T and Amaral DC and Veiga DM and Oliveira AKR and Gonzalez JVP and Silva LO and Caixeta GL and Maia M and Louzada RN.},
journal = {American journal of ophthalmology},
year = {2026},
doi = {10.1016/j.ajo.2026.11.005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Internal Medicine 2006
Citation only
Age-Related Macular Degeneration and Risk for Stroke
Singapore National Eye Centre 2025
Open access · US-GOV
Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study
JAMA Ophthalmology 2017
Open access · OA
Association Between C-Reactive Protein and Age-Related Macular Degeneration
BMC Ophthalmology 2010
Open access · CC-BY
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Archives of Ophthalmology 2002
Open access · OA
Effect of Depression on Vision Function in Age-Related Macular Degeneration
Journal of Ophthalmology 2013
Open access · CC-BY